45
Participants
Start Date
November 30, 2010
Primary Completion Date
December 31, 2012
Study Completion Date
February 28, 2013
cαStx1/cαStx2
cαStx1/cαStx2 administered concomitantly at a dose of 1 mg/kg (low dose cohort) or 3 mg/kg (high dose cohort)per antibody over 1 hour + standard of care
Placebo
Placebo administered over 1 hour + standard of care
Bahía Blanca
Buenos Aires
Córdoba
La Plata
Mendoza
Paraná
San Miguel de Tucumán
Concepción
Santiago
Valparaíso
Lima
Lead Sponsor
Collaborators (1)
LFB Biotechnologies, SAS
UNKNOWN
Thallion Pharmaceuticals
INDUSTRY